Stockscreener 앱 받기
8.5903
2.01%
0.1503
전일 마감가:
$8.44
열려 있는:
$8.51
하루 거래량:
113.30K
Relative Volume:
1.03
시가총액:
$105.54M
수익:
$57.70M
순이익/손실:
$11.98M
주가수익비율:
-14.95
EPS:
-0.5746
순현금흐름:
$-12.24M
1주 성능:
+5.00%
1개월 성능:
+49.48%
6개월 성능:
-26.35%
1년 성능:
-30.95%
1일 변동 폭
$8.4201
$8.70
1주일 범위
$7.99
$8.74
52주 변동 폭
$4.95
$12.96
Lensar Inc Stock (LNSR) Company Profile
명칭
Lensar Inc
전화
888-536-7271
주소
2800 DISCOVERY DRIVE, ORLANDO
Compare LNSR vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LNSR
Lensar Inc
|
8.59 | 107.13M | 57.70M | 11.98M | -12.24M | -0.5746 |
ABT
Abbott Laboratories
|
116.25 | 198.01B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
330.75 | 130.41B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
92.85 | 120.48B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
50.45 | 75.37B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
89.54 | 53.19B | 6.30B | 1.07B | 1.09B | 1.8406 |
Lensar Inc Stock (LNSR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-01 | 업그레이드 | Lake Street | Hold → Buy |
| 2026-03-18 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2021-02-24 | 개시 | SVB Leerink | Outperform |
Lensar Inc 주식(LNSR)의 최신 뉴스
LENSAR (LNSR) Q2 2026 Earnings Call Transcript - AOL.com
LENSAR (NASDAQ:LNSR) Price Target Raised to $10.00 - MarketBeat
LNSR Maintains Buy Rating by BTIG -- Price Target Raised to $10. - GuruFocus
DCF Advisers LLC Purchases New Position in LENSAR, Inc. $LNSR - MarketBeat
LENSAR (LNSR) Session: Ends Up by 1.71% at $8.33 in Latest Trading; Price Context: $7.91 and $8.75 Define the Nearby Reference Levels for the Current SessionRSI Overbought Alerts - Vinanet
LENSAR (LNSR) Trading Summary: Gains 1.24% to Reach $8.19 in Latest Trading; Range Context: the Current Price Sits Inside the Supplied Technical Range at the CloseCall Resistance - Vinanet
LNSR Q2 2026 Earnings: EPS Swings to Profit, Delivering 159.42% SurpriseEarnings Momentum Score - Vinanet
LNSR Looks 65.7% Overvalued on GF Value™ - GuruFocus
Trading the Move, Not the Narrative: (LNSR) Edition - Stock Traders Daily
LNSR Q2 2026 Earnings: Strong EPS Beat vs. Estimates Despite Soft Share ReactionNext Quarter Guidance - Vinanet
LENSAR Q2 recurring revenue hits USD 13.7M - Medical Buyer
LENSAR Inc. (LNSR) Holds Above Support at $8.20 After Modest PullbackRounding Bottom - Vinanet
LENSAR (NASDAQ:LNSR) Upgraded at Wall Street Zen - MarketBeat
Lensar Stock Slumps After Hours On Ending Merger Deal With Alcon Over FTC Pushback - Stocktwits
Curis: Q2 Earnings Snapshot - AOL.com
Lake Street Maintains LENSAR(LNSR.US) With Buy Rating, Maintains Target Price $13 - Moomoo
LENSAR-Ergebniskonferenz Q2 2026: Umsatz steigt um 18 % dank steigender wiederkehrender Umsätze - TradingKey
LENSAR earnings beat by $0.31, revenue topped estimates - Investing.com Canada
Q2 2026 LENSAR Inc Earnings Call Transcript - GuruFocus
Lensar Returns to Profit in Q2 on Strong Demand for ALLY Cataract System - VisionMonday.com
LENSAR Inc (LNSR) (Q2 2026) Earnings Call Highlights: Record Rev - GuruFocus
LENSAR Inc (LNSR) (Q2 2026) Earnings Call Highlights: Record Revenue and Profitability Surge - Yahoo Finance
LENSAR (LNSR) swings to profit on $39.9M H1 net income and $10M merger fee - Stock Titan
LNSR Looks 44.6% Overvalued on GF Value™ - GuruFocus
LNSR Q2 2026 Earnings: EPS Beats Estimates by Wide Margin, Shares Surge 29.41%Core Business Growth - Vinanet
LENSAR (NASDAQ:LNSR) Posts Quarterly Earnings Results, Beats Expectations By $0.26 EPS - MarketBeat
Lake Street Maintains LENSAR(LNSR.US) With Buy Rating, Raises Target Price to $13 - Moomoo
LENSAR Q2 Earnings Call Highlights - MarketBeat
LENSAR, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
LNSR Maintained by BTIG -- Price Target Raised to $9.00 - GuruFocus
BTIG Research Forecasts Strong Price Appreciation for LENSAR (NASDAQ:LNSR) Stock - MarketBeat
Earnings call transcript: LENSAR beats on Q2 2026 profit, shares jump premarket - Investing.com Canada
LENSAR Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Lensar Q2 EPS $0.10 beats estimate; sales up 18% to $16.5M - scanx.trade
Why is LENSAR stock surging today? By Investing.com - Investing.com South Africa
Why is LENSAR stock surging today? - Investing.com India
Is LENSAR Inc (LNSR) Overvalued After Q2 Earnings? EPS: $0.13, R - GuruFocus
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Form 8K LENSAR Inc For: 13 August By Investing.com - Investing.com Nigeria
LENSAR Q2 Revenue Rises 18% as Net Income Reaches $3.5 Million - Quiver Quantitative
LENSAR Reports Q2 2026: Revenue $16.5M, Recurring Revenue $13.7M, Net Income $3.5M - TradingView
LENSAR (LNSR) swings to Q2 2026 profit as revenue and ALLY usage climb - Stock Titan
LENSAR® Reports Second Quarter 2026 Results and Provides Business Update - marketscreener.com
LENSAR Places 10 Robotic Cataract Lasers; 13 Await Installation - Stock Titan
LENSAR Q2 FY26 net income turns to USD 3.5 million; revenue rises 18% to USD 16.5 million - Bitget
Earnings To Watch: LENSAR Inc (LNSR) Q2 2026 -- GF Value Sees 13% Upside - Yahoo Finance
LENSAR Inc. (LNSR) Advances 4.31% to $6.29 as Shares Test ResistanceThrowback Trade - Vinanet
Lensar System Receives FDA Clearance - Photonics Spectra
LENSAR Shareholders Approve Directors and Executive Pay - TipRanks
LENSAR Inc (LNSR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Earnings Preview: LENSAR to Report Financial Results Pre-market on August 13 - Moomoo
Lensar Inc (LNSR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.26%
0.20%
자본화:
|
볼륨(24시간):